Stockscreener 앱 받기
11.53
3.88%
-0.465
시간 외 거래:
11.56
0.035
+0.30%
Regenxbio Inc 주식(RGNX)의 최신 뉴스
REGENXBIO advances gene therapies for diabetic retinopathy - Traders Union
REGENXBIO (NASDAQ:RGNX) Stock Price Down 9.8%Here's What Happened - MarketBeat
Regenxbio Inc expected to post a loss of $1.31 a shareEarnings Preview - TradingView
Will REGENXBIO Inc. (RB0) stock announce special dividend2025 Market Overview & Consistent Income Trade Ideas - newser.com
Will REGENXBIO Inc. stock split again soonJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
How REGENXBIO Inc. stock responds to policy changesTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Using economic indicators to assess REGENXBIO Inc. potentialQuarterly Trade Review & Weekly Market Pulse Updates - newser.com
Is now a turning point for REGENXBIO Inc.Gap Down & Expert Approved Trade Ideas - newser.com
Will REGENXBIO Inc. (RB0) stock sustain uptrend momentumJuly 2025 Gainers & Weekly Breakout Opportunity Watchlist - newser.com
Will REGENXBIO Inc. (RB0) stock profit from fiscal stimulusWeekly Gains Report & Community Verified Trade Alerts - newser.com
Will REGENXBIO Inc. stock go up soon2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - newser.com
Reversal indicators forming on REGENXBIO Inc. stock2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
REGENXBIO Inc. stock daily chart insightsJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
What data driven models say about REGENXBIO Inc.’s future2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
Visualizing REGENXBIO Inc. stock with heatmapsJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Will REGENXBIO Inc. stock see PE expansionQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Historical volatility pattern of REGENXBIO Inc. visualizedEarnings Overview Summary & Long-Term Safe Investment Plans - newser.com
Should I buy REGENXBIO Inc. (RB0) stock before earnings seasonTrade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
Is REGENXBIO Inc. stock undervalued vs historical averagesGold Moves & Detailed Earnings Play Alerts - newser.com
Using Ichimoku Cloud for REGENXBIO Inc. technicals2025 Price Targets & AI Driven Stock Movement Reports - newser.com
Price momentum metrics for REGENXBIO Inc. explainedMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Analyzing recovery setups for REGENXBIO Inc. investorsMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Can REGENXBIO Inc. (RB0) stock deliver strong annual returnsWeekly Trade Summary & Growth-Oriented Investment Plans - newser.com
Why REGENXBIO Inc. stock is considered a top pickAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Why REGENXBIO Inc. stock appeals to dividend seekersPortfolio Value Summary & Long-Term Growth Plans - newser.com
Is REGENXBIO Inc. stock overvalued by current metricsCEO Change & Weekly Watchlist for Hot Stocks - newser.com
AlphaQuest LLC Cuts Position in REGENXBIO Inc. $RGNX - MarketBeat
REGENXBIO Inc. (NASDAQ:RGNX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
RegenXBio (RGNX) Receives a Buy from H.C. Wainwright - The Globe and Mail
Will REGENXBIO Inc. (RB0) stock outperform Dow Jones2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
REGENXBIO concludes subject enrolment in trial of RGX-202 - Clinical Trials Arena
1.45%
0.86%
자본화:
|
볼륨(24시간):